The global professional dental care market is estimated to grow at a CAGR of 4.5% from 2016 to 2021 to reach USD 961.0 Million by 2021. Factors such as growing number of small/ private dental clinics, rising incidences...
The global real world evidence solutions market in terms of revenue was estimated to be worth $1.5 billion in 2022 and is poised to reach $2.9 billion by 2027, growing at a CAGR of 15.2% from 2022 to 2027....
The rising prevalence of end-stage renal disease (ESRD), diabetes, and hypertension is stimulating the demand for dialysis treatment in the emerging nations. Furthermore, low preference of patients for kidney transplantation, technological advancements, and substantial government healthcare expenditure on the...
The global interventional radiology products market is projected to reach USD 14.1 billion by 2026, at a CAGR of 6.6% during the forecast period. The growth in this market can be attributed to the rising prevalence of chronic diseases,...
The global osteoarthritis therapeutics market in terms of revenue was estimated to be worth $7.3 billion in 2020 and is poised to reach $11.0 million by 2025, growing at a CAGR of 8.7% from 2020 to 2025.
The Growth in this market is driven by the using consistent, standardized clinical terminology to help medical practitioners access and understand clinical data found in healthcare applications, government initiatives to adopt HCIT solutions, and fragmentation in terms of medical...
Growth in this market is driven mainly by the increasing incidence of chronic diseases, government investments for cell-based research, the growing focus on personalized medicine, increasing focus on R&D for cell-based therapies, and growing GMP certifications for cell therapy...
The competitive landscape includes the analysis of the key growth strategies adopted by major players between 2018–2020 to expand their global presence and increase their market shares in the embolotherapy market. The key growth strategies adopted by the top...
The significant rise in demand for CRRT in the treatment of hemodynamically unstable patients. Moreover, the development and commercialization of novel renal replacement solutions also support market growth. Furthermore, many companies are expanding their dialysate product portfolios. For instance,...
The prostate gland (the prostate) is an organ of the male reproductive system. The three most common forms of prostate disease are inflammation (prostatitis), non-cancerous enlargement of the prostate (benign prostatic hyperplasia, or BPH), and prostate cancer. Benign prostatic...